Eli Lilly has announced that it has entered into a definitive agreement to acquire Ventyx Biosciences, a biopharmaceutical ...

Over 3.4 million people globally are affected by SLE, and it is one of the leading causes of death in young women in the US ...

The event will include a Keynote Panel discussion with noted speakers from the NHS, the King’s Fund, the ABPI and the ABHI ...

Amgen has announced a deal with the US government that will lower the company’s prescription drug costs for US patients while ...

GlaxoSmithKline’s (GSK) Nucala (mepolizumab) has been approved by the MHRA to treat adults with uncontrolled chronic ...

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, ...

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product ...

On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, ...

As part of the three-year agreement, Gilead has agreed to take a series of actions that align with the government’s new drug ...

Novartis has announced an agreement with the US government to lower the prices of its medicines in the US and support ...

Merck (known as MSD outside the US) has announced an agreement with the US government to provide key products to patients at ...

Novo Nordisk’s Wegovy (semaglutide) pill has been approved by the US FDA as an oral weight loss medication. In addition to ...